Lungs News and Research

RSS

$74 million allocated to study environmental causes of disease

As part of the new Exposure Biology Program, the National Institute of Environmental Health Sciences, a component of the National Institutes of Health, today announced $74 million in grant opportunities for the development of new technologies that will improve the measurement of environmental exposures that contribute to human disease.

19 Oct 2006

Idaho woman files lawsuit over Ortho Evra patch

A woman in Idaho who said she developed a blood clot disorder after using the birth control patch Ortho Evra -- made by Ortho-McNeil, a subsidiary of Johnson & Johnson -- has filed a lawsuit in federal court against the companies, the AP/Houston Chronicle reports.

19 Oct 2006

One in four smokers doomed to get incurable lung disease

According to British and Danish researchers the longer someone smokes the higher their risk of developing the incurable lung condition chronic obstructive pulmonary disease (COPD).

18 Oct 2006

Underlying causes, frequencies, and outcomes of dilated cardiomyopathy

The mystery behind a commonly untreatable and undetected heart muscle disease in children is partially revealed for the first time in today's edition of the scientific journal JAMA.

17 Oct 2006

Researchers step toward therapy for respiratory syncytial virus

When a child under the age of 2 contracts a respiratory tract infection requiring hospitalization, odds are that the cause is respiratory syncytial virus (RSV).

17 Oct 2006

Transport mechanism of bioactive molecule, S1P, identified

Virginia Commonwealth University researchers have identified how a bioactive molecule involved with allergy, inflammation and cancer is transported out of mast cells, according to findings published online this week in the Proceedings of the National Academy of Sciences.

17 Oct 2006

Incidence of kidney damage associated with coronary artery bypass surgery has increased significantly

The incidence of kidney damage associated with coronary artery bypass surgery has increased significantly over the past 16 years in the United States, but the rate of death from such damage has decreased significantly during the period, according to a new analysis.

16 Oct 2006

Heme oxygenase-1 protects against lung damage in silicosis

Levels of heme oxygenase-1 (HO-1), an antioxidant that protects against reactive oxygen species (damaging oxygen molecules that cause direct tissue injury), become elevated in the lungs of chronic silicosis patients and could represent a new treatment approach for the disease.

16 Oct 2006

Missouri tobacco tax proposal to appear on November ballot

The Missouri Supreme Court on Wednesday ruled unanimously that a proposed constitutional amendment to raise tobacco taxes should be placed on the Nov. 7 ballot, the St. Louis Post-Dispatch reports.

16 Oct 2006

Smoking ban already showing health benefits

Smoking bans which were implemented in most workplaces such as pubs and restaurants in Scotland in March this year, are already showing health benefits.

11 Oct 2006

Lower PSA in obese men could be a warning

Researchers in the U.S. say that obese men have lower levels of a protein used to screen for prostate cancer risk, and doctors should take weight into account when determining a man's risk.

10 Oct 2006

FDA approves Zolinza for the treatment of cutaneous T-cell lymphoma

The U.S. Food and Drug Administration (FDA) has approved Zolinza (vorinostat) capsules for the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.

8 Oct 2006

World challenge to improve air quality

The World Health Organization (WHO) is today challenging governments around the world to improve air quality in their cities in order to protect people's health.

5 Oct 2006

One-third of infant deaths occur in prem babies

Almost twice as many infant deaths than previously estimated, are because babies are born prematurely.

2 Oct 2006

Super chow, laced with semi-synthetic vitamin E derivative, inhibited spread of cancer in mice

A chemically altered form of vitamin E mixed into mouse chow dramatically reduced spread of aggressive mammary cancer in mice, suggesting that the compound in pill form could be used to treat human metastatic cancer, according to a report in the October 1 issue of the journal Cancer Research.

2 Oct 2006